115 related articles for article (PubMed ID: 12851472)
1. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
Cell Cycle; 2003; 2(4):281-2. PubMed ID: 12851472
[No Abstract] [Full Text] [Related]
2. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443
[TBL] [Abstract][Full Text] [Related]
3. Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation.
Sasaki A; Taketomi T; Wakioka T; Kato R; Yoshimura A
J Biol Chem; 2001 Sep; 276(39):36804-8. PubMed ID: 11495895
[TBL] [Abstract][Full Text] [Related]
4. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
5. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling.
Wong ES; Fong CW; Lim J; Yusoff P; Low BC; Langdon WY; Guy GR
EMBO J; 2002 Sep; 21(18):4796-808. PubMed ID: 12234920
[TBL] [Abstract][Full Text] [Related]
6. Sprouty4 negatively regulates protein kinase C activation by inhibiting phosphatidylinositol 4,5-biphosphate hydrolysis.
Ayada T; Taniguchi K; Okamoto F; Kato R; Komune S; Takaesu G; Yoshimura A
Oncogene; 2009 Feb; 28(8):1076-88. PubMed ID: 19137008
[TBL] [Abstract][Full Text] [Related]
7. Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signaling.
Kiel C; Serrano L
Sci Signal; 2009 Jul; 2(81):ra38. PubMed ID: 19638615
[TBL] [Abstract][Full Text] [Related]
8. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T
Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367
[TBL] [Abstract][Full Text] [Related]
9. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929.
Huang WC; Chio CC; Chi KH; Wu HM; Lin WW
Exp Cell Res; 2002 Jul; 277(2):192-200. PubMed ID: 12083801
[TBL] [Abstract][Full Text] [Related]
10. Neural cell adhesion molecule-stimulated neurite outgrowth depends on activation of protein kinase C and the Ras-mitogen-activated protein kinase pathway.
Kolkova K; Novitskaya V; Pedersen N; Berezin V; Bock E
J Neurosci; 2000 Mar; 20(6):2238-46. PubMed ID: 10704499
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-10 attenuates H2O2-induced alveolar epithelial cell DNA damage: role of MAPK activation and DNA repair.
Upadhyay D; Bundesmann M; Panduri V; Correa-Meyer E; Kamp DW
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):107-13. PubMed ID: 14975937
[TBL] [Abstract][Full Text] [Related]
12. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf.
Yusoff P; Lao DH; Ong SH; Wong ES; Lim J; Lo TL; Leong HF; Fong CW; Guy GR
J Biol Chem; 2002 Feb; 277(5):3195-201. PubMed ID: 11698404
[TBL] [Abstract][Full Text] [Related]
13. Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis.
Hood JD; Frausto R; Kiosses WB; Schwartz MA; Cheresh DA
J Cell Biol; 2003 Sep; 162(5):933-43. PubMed ID: 12952943
[TBL] [Abstract][Full Text] [Related]
14. Spred is a Sprouty-related suppressor of Ras signalling.
Wakioka T; Sasaki A; Kato R; Shouda T; Matsumoto A; Miyoshi K; Tsuneoka M; Komiya S; Baron R; Yoshimura A
Nature; 2001 Aug; 412(6847):647-51. PubMed ID: 11493923
[TBL] [Abstract][Full Text] [Related]
15. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
[TBL] [Abstract][Full Text] [Related]
16. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.
Satyamoorthy K; Li G; Gerrero MR; Brose MS; Volpe P; Weber BL; Van Belle P; Elder DE; Herlyn M
Cancer Res; 2003 Feb; 63(4):756-9. PubMed ID: 12591721
[TBL] [Abstract][Full Text] [Related]
17. Ras/Raf signalling and emerging pharmacotherapeutic targets.
Kolch W
Expert Opin Pharmacother; 2002 Jun; 3(6):709-18. PubMed ID: 12036410
[TBL] [Abstract][Full Text] [Related]
18. Suppression of integrin activation by activated Ras or Raf does not correlate with bulk activation of ERK MAP kinase.
Hughes PE; Oertli B; Hansen M; Chou FL; Willumsen BM; Ginsberg MH
Mol Biol Cell; 2002 Jul; 13(7):2256-65. PubMed ID: 12134066
[TBL] [Abstract][Full Text] [Related]
19. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.
Kolch W
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):289-305. PubMed ID: 11023813
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase requirement in activation of the ras/C-raf-1/MEK/ERK and p70(s6k) signaling cascade by the insulinomimetic agent vanadyl sulfate.
Pandey SK; Théberge JF; Bernier M; Srivastava AK
Biochemistry; 1999 Nov; 38(44):14667-75. PubMed ID: 10545192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
